References

Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European Society of Cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure: endorsed by the Canadian heart failure society, heart failure association of India, cardiac society of Australia and New Zealand, and Chinese heart failure association

10.1002/ejhf.2115 · 2021 · External reference

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

10.1093/eurheartj/ehab368 · 2021 · External reference

Biomarkers for the diagnosis and management of heart failure

10.1007/s10741-021-10105-w · 2022 · External reference

Heart failure and liver disease: cardiohepatic interactions

10.1016/j.jchf.2018.10.007 · 2019 · External reference

Liver disease and heart failure: back and forth

10.1016/j.ejim.2017.10.016 · 2018 · External reference

Hepatic ischemia-reperfusion injury: protective approaches and treatment

10.2174/1874467217666230803114856 · 2024 · External reference

Overexpression of Serum Sst2 is associated with poor prognosis in acute-on-chronic hepatitis B liver failure

10.1016/j.clinre.2014.10.012 · 2015 · External reference

Evaluation of soluble suppression of tumorigenicity 2 (Sst2) as Serum marker for liver fibrosis

10.1186/s12876-023-03116-4 · 2024 · External reference

Plasma levels of soluble St2, but not il-33, correlate with the severity of alcoholic liver disease

10.1111/jcmm.13990 · 2019 · External reference

Prognostic value of Sst2 in heart failure

10.3390/jcm12123970 · 2023 · External reference

2022 Aha/acc/hfsa guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines

10.1016/j.jacc.2021.12.012 · 2022 · External reference

Cardiac biomarkers in the emergency department: the role of soluble St2 (Sst2) in acute heart failure and acute coronary syndrome-there is meat on the bone

10.3390/jcm8020270 · 2019 · External reference

The il-33/St2 pathway: therapeutic target and novel biomarker

10.1038/nrd2660 · 2008 · External reference

Il-33/St2 axis in diverse diseases: regulatory mechanisms and therapeutic potential

10.3389/fimmu.2025.1533335 · 2025 · External reference

Chinese Guidelines for the diagnosis and treatment of heart failure 2024

10.26599/1671-5411.2025.03.002 · 2025 · External reference

Expert consensus on diagnosis and treatment of acute liver injury in the emergency setting

10.3969/j.issn.1002-1949.2024.01.002 · 2024 · External reference

Abnormal liver function in relation to hemodynamic profile in heart failure patients

10.1016/j.cardfail.2009.08.002 · 2010 · External reference

Cardiohepatic interactions in heart failure: an overview and clinical implications

10.1016/j.jacc.2013.03.042 · 2013 · External reference

Liver function abnormalities and outcome in patients with chronic heart failure: data from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program

10.1093/eurjhf/hfn031 · 2009 · External reference

Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance

10.1111/j.1365-2362.2011.02573.x · 2012 · External reference

The biology of St2: the international St2 consensus panel

10.1016/j.amjcard.2015.01.034 · 2015 · External reference

Gasdermin D-mediated release of il-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma

10.1126/sciimmunol.abl7209 · 2022 · External reference

Pulmonary production of soluble St2 in heart failure

10.1161/circheartfailure.118.005488 · 2018 · External reference

Prognostic implication of liver function tests in heart failure with preserved ejection fraction without chronic hepatic diseases: insight from topcat trial

10.3389/fcvm.2021.618816 · 2021 · External reference

Ast/alt ratio predicts the functional severity of chronic heart failure with reduced left ventricular ejection fraction

10.1186/s13104-020-05031-3 · 2020 · External reference

Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the acute heart failure committee of the heart failure association (hfa) of the European Society of Cardiology (esc)

10.1002/ejhf.872 · 2017 · External reference

Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases

10.1097/01.md.0000101573.54295.bd · 2003 · External reference

Hypoxic hepatitis: a review and clinical update

10.14218/jcth.2016.00022 · 2016 · External reference

Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells

10.1038/cmi.2016.63 · 2017 · External reference

Soluble St2: a Complex and diverse role in several diseases

10.1016/j.cca.2020.04.011 · 2020 · External reference

Il-33 and St2 comprise a critical biomechanically induced and cardioprotective signaling system

10.1172/jci30634 · 2007 · External reference

Diagnostic and prognostic value of nt-probnp in patients with non-alcoholic fatty liver disease and acute decompensated heart failure

10.1093/ehjacc/zuae036.070 · 2024 · External reference